Drug Class
Bruton's tyrosine kinase inhibitor
Type
brand
Active Ingredient
ibrutinib
📋Overview
Imbruvica is a medication used in the management of certain types of blood cancers, such as chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia. It works by targeting specific proteins involved in the growth and survival of cancerous cells. Imbruvica is part of a class of drugs known as Bruton's tyrosine kinase inhibitors. Its use has expanded to include various lymphoid malignancies and related conditions.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Imbruvica
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.